Healthy Japanese subjects
Conditions
Interventions
Duration: One day Test product: A mixed aqueous solution of ingredients for cosmetics containing snail secretion Administration: Apply 3 mg/cm2 (3 micro L/cm2, in total 27 micro L) of the test produ
Sponsors
ORTHOMEDICO Inc.
Medical Corporation Seishinkai, Takara Clinic Nerima Medical Association, Minami-machi Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Japanese 2. Men or women 3. Healthy subjects 4. Subjects aged 20 or more and less than 45 5. Subjects whose moisture of the skin is relatively low among study participants at screening (before consumption; Scr) 6. Subjects who have no abnormality in the skin patch test at Scr
Exclusion criteria
Exclusion criteria: 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5. Subjects who have been diagnosed with atopic dermatitis 6. Subjects who have abnormalities of skin or body constitution 7. Subjects who have experienced skin rash, redness, itching, feeling of irritation, or other skin abnormalities due to the use of cosmetics or other products 8. Subjects who use any products except for cosmetic creams, beauty essence, all-in-one cosmetic makeup, skin lotions such as face masks, milky lotions, and sunscreen for daily skincare 9. Subjects who habitually receive skincare treatment (e.g., aesthetic treatment) or use instruments for beauty treatment (e.g., facial treatment device) 10. Subjects who are currently taking medications (including herbal medicines) and supplements 11. Subjects who are allergic to medicines and/or the test product related products 12. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 13. Subjects who suffer from COVID-19 14. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 15. Subjects who are judged as ineligible to participate in this study by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The moisture of the skin, transepidermal water loss, and viscoelasticity of the skin | — |
Countries
Japan
Contacts
Public ContactNaoko Suzuki
ORTHOMEDICO Inc. R&D Department
Outcome results
None listed